594 related articles for article (PubMed ID: 18922724)
1. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
[TBL] [Abstract][Full Text] [Related]
2. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis.
Brennan AL; Gyi KM; Wood DM; Hodson ME; Geddes DM; Baker EH
J Cyst Fibros; 2006 Jan; 5(1):27-31. PubMed ID: 16202666
[TBL] [Abstract][Full Text] [Related]
3. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
[TBL] [Abstract][Full Text] [Related]
4. Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes?
Narbonne H; Renacco E; Pradel V; Portugal H; Vialettes B
Diabetes Metab; 2001 Nov; 27(5 Pt 1):598-603. PubMed ID: 11694860
[TBL] [Abstract][Full Text] [Related]
5. Sputum glucose and glycemic control in cystic fibrosis-related diabetes: a cross-sectional study.
Van Sambeek L; Cowley ES; Newman DK; Kato R
PLoS One; 2015; 10(3):e0119938. PubMed ID: 25803537
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
GoĊembiewska E
Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
[TBL] [Abstract][Full Text] [Related]
7. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
[TBL] [Abstract][Full Text] [Related]
8. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.
Rohlfing CL; Wiedmeyer HM; Little RR; England JD; Tennill A; Goldstein DE
Diabetes Care; 2002 Feb; 25(2):275-8. PubMed ID: 11815495
[TBL] [Abstract][Full Text] [Related]
9. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
[TBL] [Abstract][Full Text] [Related]
10. Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.
Tommerdahl KL; Brinton JT; Vigers T; Nadeau KJ; Zeitler PS; Chan CL
Pediatr Diabetes; 2019 Dec; 20(8):1080-1086. PubMed ID: 31469470
[TBL] [Abstract][Full Text] [Related]
11. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.
Makris K; Spanou L; Rambaouni-Antoneli A; Koniari K; Drakopoulos I; Rizos D; Haliassos A
Diabet Med; 2008 Feb; 25(2):174-8. PubMed ID: 18290858
[TBL] [Abstract][Full Text] [Related]
12. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
[TBL] [Abstract][Full Text] [Related]
13. Relationship between glycated haemoglobin levels and mean glucose levels over time.
Nathan DM; Turgeon H; Regan S
Diabetologia; 2007 Nov; 50(11):2239-44. PubMed ID: 17851648
[TBL] [Abstract][Full Text] [Related]
14. Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4.
Chen HS; Wu TE; Lin HD; Jap TS; Hsiao LC; Lee SH; Lin SH
Am J Kidney Dis; 2010 May; 55(5):867-74. PubMed ID: 20202728
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobin A
Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
[TBL] [Abstract][Full Text] [Related]
16. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?
Kuenen JC; Borg R; Kuik DJ; Zheng H; Schoenfeld D; Diamant M; Nathan DM; Heine RJ;
Diabetes Care; 2011 Aug; 34(8):1843-7. PubMed ID: 21700921
[TBL] [Abstract][Full Text] [Related]
17. Cystic Fibrosis-Related Diabetes Screening in Adults: A Gap Analysis and Evaluation of Accuracy of Glycated Hemoglobin Levels.
Gilmour JA; Sykes J; Etchells E; Tullis E
Can J Diabetes; 2019 Feb; 43(1):13-18. PubMed ID: 30173928
[TBL] [Abstract][Full Text] [Related]
18. The use of fructosamine in cystic fibrosis-related diabetes (CFRD) screening.
Lam GY; Doll-Shankaruk M; Dayton J; Rodriguez-Capote K; Higgins TN; Thomas D; Mulchey K; Smith MP; Brown NE; Leung WM; Estey MP
J Cyst Fibros; 2018 Jan; 17(1):121-124. PubMed ID: 28648493
[TBL] [Abstract][Full Text] [Related]
19. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
Pickup JC; Freeman SC; Sutton AJ
BMJ; 2011 Jul; 343():d3805. PubMed ID: 21737469
[TBL] [Abstract][Full Text] [Related]
20. Nontraditional markers of glycemia: associations with microvascular conditions.
Selvin E; Francis LM; Ballantyne CM; Hoogeveen RC; Coresh J; Brancati FL; Steffes MW
Diabetes Care; 2011 Apr; 34(4):960-7. PubMed ID: 21335368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]